Iron overload-related heart failure in a patient with transfusion-dependent myelodysplastic syndrome reversed by intensive combined chelation therapy

被引：4

作者：

Pinto, Valeria ^{[1
]}

Balocco, Manuela ^{[1
]}

Ambaglio, Ilaria ^{[2
]}

Derchi, Giorgio ^{[3
]}

Malcovati, Luca ^{[2
]}

Forni, Gian Luca ^{[1
]}

机构：

[1] Osped Galliera, Ematol Ctr Microcitemia & Anemie Congenite, Via Volta 6, I-16128 Genoa, Italy

[2] Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Dept Hematol Oncol, I-27100 Pavia, Italy

[3] Osped Galliera, Unit Cardiol, Genoa, Italy

来源：

CLINICAL CASE REPORTS | 2015年 / 3卷 / 11期

关键词：

Deferiprone; desferal; heart failure; iron chelation; myelodysplastic syndromes;

D O I：

10.1002/ccr3.407

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Key Clinical Message Patients with transfusion-dependent myelodysplastic syndromes (MDS) have an increased risk of cardiac events, due to both chronic anemia and iron overload. Here, we report the recovery of cardiac function after an intensive iron chelation therapy in a MDS patient who had developed heart failure due to iron overload.

引用

页码：952 / 954

页数：3

共 50 条

[21] Effect of iron chelator deferasirox on chronic anemia and thrombocytopenia in a transfusion-dependent patient with myelodysplastic syndrome
Nishiuchi, Takamasa
Okutani, Yuichi
Fujita, Toshikazu
Yoshida, Kazuya
Ohnishi, Hiroaki
Haba, Reiji
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (02) : 333 - 335
[22] Iron chelation therapy in the management of transfusion-related cardiac iron overload
Fernandes, Juliano Lara
TRANSFUSION, 2012, 52 (10) : 2256 - 2268
[23] Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
Bou-Fakhredin, Rayan
Bazarbachi, Abdul-Hamid
Chaya, Bachar
Sleiman, Joseph
Cappellini, Maria Domenica
Taher, Ali T.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (12)
[24] Safety of Combined Chelation Therapy with Deferasirox and Deferoxamine in Transfusion-Dependent Thalassemia.
Lal, Ashutosh
Sweeters, Nancy
Herz, Matt
Foote, Dru
Neumayr, Lynne
Kurio, Greg
Harmatz, Paul R.
Vichinsky, Elliott P.
BLOOD, 2009, 114 (22) : 798 - 798
[25] IRON CHELATION-THERAPY WITH DEFEROXAMINE FOR TRANSFUSION-DEPENDENT REFRACTORY-ANEMIA
FRAME, JN
CHIKKAPPA, G
BLOOD, 1994, 84 (10) : A547 - A547
[26] Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia
Jamuar, Saumya S.
Lai, Angeline H. M.
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (05) : 299 - 307
[27] Safety and Efficacy of the New Combination Iron Chelation Regimens in Patients with Transfusion-Dependent Thalassemia and Severe Iron Overload
Origa, Raffaella
Cinus, Monia
Pilia, Maria Paola
Gianesin, Barbara
Zappu, Antonietta
Orecchia, Valeria
Clemente, Maria Grazia
Pitturru, Carla
Denotti, Anna Rita
Corongiu, Francesco
Piras, Simona
Barella, Susanna
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
[28] RBC Exchange Transfusion As an Adjunct Therapy to Control Iron Overload in Patients with Transfusion-Dependent Thalassemia
Jackson, Amanda Claire
Schissel, Makayla
Harper, James
Bobr, Aleh
BLOOD, 2023, 142
[29] Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements
Angel F. Remacha
Beatriz Arrizabalaga
Consuelo Del Cañizo
Guillermo Sanz
Ana Villegas
Annals of Hematology, 2010, 89 : 147 - 154
[30] Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements
Remacha, Angel F.
Arrizabalaga, Beatriz
Del Canizo, Consuelo
Sanz, Guillermo
Villegas, Ana
ANNALS OF HEMATOLOGY, 2010, 89 (02) : 147 - 154

← 1 2 3 4 5 →